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Abstract
Background: The aim of this study was to elucidate the possible role of cerebral saturation monitoring in the
post-cardiac arrest setting.
Methods: Cerebral tissue saturation (SctO2) was measured in 107 successfully resuscitated out-of-hospital cardiac arrest
patients for 48 hours between 2011 and 2015. All patients were treated with targeted temperature management,
24 hours at 33 °C and rewarming at 0.3 °C per hour. A threshold analysis was performed as well as a linear mixed
models analysis for continuous SctO2 data to compare the relation between SctO2 and favorable (cerebral performance
category (CPC) 1–2) and unfavorable outcome (CPC 3–4–5) at 180 days post-cardiac arrest in OHCA patients.
Results: Of the 107 patients, 50 (47 %) had a favorable neurological outcome at 180 days post-cardiac arrest. Mean
SctO2 over 48 hours was 68 % ± 4 in patients with a favorable outcome compared to 66 % ± 5 for patients with an
unfavorable outcome (p = 0.035). No reliable SctO2 threshold was able to predict favorable neurological outcome. A
significant different course of SctO2 was observed, represented by a logarithmic and linear course of SctO2 in patients
with favorable outcome and unfavorable outcome, respectively (p < 0.001). During the rewarming phase, significant
higher SctO2 values were observed in patients with a favorable neurological outcome (p = 0.046).
Conclusions: This study represents the largest post-resuscitation cohort evaluated using NIRS technology, including a
sizeable cohort of balloon-assisted patients. Although a significant difference was observed in the overall course of
SctO2 between OHCA patients with a favorable and unfavorable outcome, the margin was too small to likely represent
functional outcome differentiation based on SctO2 alone. As such, these results given such methodology as performed
in this study suggest that NIRS is insufficient by itself to serve in outcome prognostication, but there may remain
benefit when incorporated into a multi-neuromonitoring bedside assessment algorithm.
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Background
During a cardiac arrest (CA), the brain is exposed to
hypoxia resulting in neurological injury and determining
survival in the majority of the post-CA patients. The
brain is namely a highly aerobic organ with a limited
capacity to store energy, necessitating a constant delivery
of oxygen and glucose. Regardless of the recent advances
in cardiopulmonary resuscitation and post-resuscitation
care, neurological injury still remains a major problem.
Almost 70 % of patients who die during their hospital
stay after out-of-hospital cardiac arrest (OHCA) decease
due to post-anoxic neurological injury [1]. This may be
explained by the fact that the brain of an OHCA patient
is subjected to a sequence of pathophysiological changes
during the arrest itself, but also during the return of spon-
taneous circulation (ROSC) and in the post-resuscitation
phase. First, global ischemia of the brain occurs during the
arrest which accounts for the primary neurological injury.
Next, after ROSC is achieved a post-CA syndrome de-
velops, which is characterized by a short-lasting cerebral
hyperemia followed by an increase in cerebrovascular
resistance finally resulting in a decrease in cerebral blood
flow (CBF) [2]. During this post-CA phase, there is an
imbalance between oxygen delivery relative to oxygen
requirements, which can last for several hours to days.
These pathophysiological changes may cause progressive
and irreversible brain injury responsible for the so-called
secondary neurological injury. Thus far, targeted
temperature management (TTM) is the only treatment
with proven efficacy on neurological outcome after
OHCA [3, 4].
Current brain monitoring techniques applied in post-CA
patients focus on the prediction of cerebral outcome rather
than on possible therapeutic implications [5]. Hence, cere-
bral hemodynamics could have an influence on outcome in
the post-CA phase. Therefore, a better understanding of
cerebral hemodynamic disturbances via cerebral monitor-
ing could have an impact on the post-CA management.
Near-infrared spectroscopy (NIRS) provides information on
brain oxygenation by monitoring the regional cerebral
oxygen saturation (SctO2) at the microvascular level.
It is a non-invasive monitoring tool to measure the
difference between oxygenated and deoxygenated
hemoglobin in venous, arterial, and capillary blood.
The aim of this study was to improve our knowledge
and to elucidate the possible role of non-invasive SctO2
during the first 48 hours after an OHCA (with use of




All comatose survivors after OHCA with presumed
cardiac origin treated in our tertiary care hospital
(Ziekenhuis Oost-Limburg, Genk, Belgium) were pro-
spectively enrolled between March 2011 and May 2015
(n = 107). Exclusion criteria were patients < 18 years and
an obviously non-cardiac cause of OHCA. If a fall was
mentioned in the hetero-anamnesis, or if any clinical signs
of a fall were present (e.g., bruises) a computed tomog-
raphy (CT) scan was performed prior to coronary care
unit (CCU) admission. If no clear cause of the arrest was
determined at arrival at the emergency department, a head
CT scan was performed to exclude cerebral causes of CA.
None of the included patients had intracerebral patholo-
gies. All patients were treated uniformly according to the
institutional post-CA protocol [6]. As part of this protocol,
SctO2 monitoring was routinely applied on arrival at the
CCU. The study protocol was approved by the local med-
ical ethics committee (Comité Medische Ethiek Ziekenhuis
Oost-Limburg 11/066). Written informed consent was
obtained from next of kin.
General management
Our institutional post-CA protocol has been described pre-
viously [6]. In summary, all patients were intubated, mech-
anically ventilated, and sedated with propofol and
remifentanil (if hemodynamically tolerated). Cisatracurium
was administered in case of shivering (bolus or continuous
infusion). Patients underwent urgent coronary angiography
followed by percutaneous coronary intervention when in-
dicated. TTM at 33 °C was induced as soon as possible
after hospital admission by cold saline (4 °C – 30 ml/kg)
and was further mechanically induced and maintained in
the CCU by endovascular (Icy™ catheter, CoolGard® 3000,
Alsius, Irvine, CA, USA) or surface (ArcticGel™ pads,
Arctic Sun® 5000, Medivance, Louisville, CO, USA) cooling
systems at 33 °C for 24 hours. Both systems are equipped
with a feedback loop controlling target temperature using
an esophageal temperature probe. Esophageal temperature
was recorded every minute during hypothermia and
rewarming. After rewarming (0.3 °C/hour for 12 hours)
sedation was titrated toward patient’s comfort with efforts
to minimize sedation. Patients were extubated when their
neurological, respiratory and hemodynamic status had
recovered sufficiently. During the first 48 hours post-CA,
an hourly blood gas was taken.
Cerebral saturation monitoring
Cerebral tissue oxygen saturation was continuously
measured with NIRS, using the FORE-SIGHT™ technol-
ogy (CAS Medical Systems, Branford, CT, USA). Sensors
were bilaterally applied to the frontotemporal area at
CCU admission, before the start of mechanically in-
duced hypothermia. Data were transmitted to a personal
computer together with all hemodynamic data with a
2-second time interval. We also calculated the area
below a preset SctO2 threshold. This value encompasses
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both duration and severity of a desaturation below a pre-
set SctO2 threshold during the first 48 hours after CA.
Since this was an observational study, treatment was
guided according to the guidelines of the European
Resuscitation Council and was not affected in any way by
the collected NIRS data although the SctO2 data were not
blinded for the treating physician [7].
Hemodynamic monitoring and management
Patients were treated according to the guidelines with
the main focus on achieving a mean arterial pressure
(MAP) above 65 mmHg [8]. If signs of inadequate circu-
lation persisted despite correct fluid resuscitation (wedge
pressure >18 mmHg), norepinephrine was infused first
with a target MAP of 65 mmHg and subsequently dobu-
tamine was given with a target cardiac index of >2.2 l/
min/m2. An intra-aortic balloon pump (IABP) was in-
stalled as deemed necessary by the treating physicians.
Blood pressures were obtained by a radial artery line
while a Swan-Ganz catheter provided information about
cardiac output (CO), cardiac index and continuous
mixed venous blood oxygen saturation (SvO2).
Outcome measurement
The cerebral performance category (CPC) scale was used
to define patient outcome [9–11]. According to the scale
classification, CPC 1 indicates good cerebral performance,
CPC 2 implies a moderate disability (sufficient for inde-
pendent activities in daily life), CPC 3 indicates severe
disability (dependent on others), CPC 4 implies coma or
vegetative state and CPC 5 stands for death. Neurological
performance was assessed at 180 days after the CA.
Statistical methods
Patients’ characteristics were compared using Student’s t
test if normally distributed and expressed as mean ±
standard deviation. The chi-square test and Fisher’s
exact test (when expected frequency of five or less) were
used to compare categorical values. Descriptive statistics
were used for continuously measured SctO2 values and
are expressed as mean ± standard deviation.
The data as collected are longitudinal in nature:
SctO2 was measured repeatedly over time. By aver-
aging SctO2 values per hours, the data yields 48 mea-
surements per patient. To take the longitudinal
nature of the data into account, a linear mixed model
with a random intercept and a random slope was
used [12].
The comparison of the evolution of SctO2 for the
survivors versus non-survivors was of primary interest.
To take possible confounders into account, an effect of
gender and age, together with a quadratic effect of time,
and all interactions with gender and survival were con-
sidered in a first, elaborated model.
A backward selection procedure was performed to
exclude non-significant effects. This resulted in the
following model:
Satij ¼ βms0 þ b0i
 þ βms1 þ b1i
 
tij þ βs2tij2 þ βms3 agei
þ βm4 tijagei þ ij Male survivors βmn0 þ b0i
 
þ βmn1 þ b1i
 
tij þ βn2tij2 þ βmn3 agei þ βm4 tijagei
þ ij Male non‐survivors βfs0 þ b0i
 




þ βfs3agei þ βf4tijagei
þ ij Female survivors βf n0 þ b0i
 




þ βf n3 agei þ βf4tijagei
þ ij Female non‐survivors
Where Satij and tij are SctO2measurement and the cor-
responding time of this measurement for patient i on
hour j, agei is the age of patient i, and






, are the random intercept and
random slope respectively. All parameters in this model
were significant, and no further reduction could be ob-
tained. A p value < 0.05 was considered to be statistically
significant. Tests were performed using IBM SPSS version
20.00 (IBM Corp., Armonk, NY, USA) and SAS Software
version 13.2 (SAS Institute, Cary, NC, USA). Figures were
made using GraphPad Prism 5.01 (GraphPad Software,
San Diego, CA, USA).
Results
One hundred and seven consecutive OHCA patients
were included in this study. Baseline characteristics are
summarized in Table 1. Fifty patients (47 %) survived
with a good neurological outcome (CPC1–2) at 180 days
post-CA. A significant difference in initial rhythm was
observed, 84 % of the survivors had ventricular fibrilla-
tion in contrast to 41 % of the non-survivors (p < 0.001).
Significantly more survivors underwent urgent coronary
angiography (92 % versus 71 %, p = 0.008) and received a
percutaneous coronary intervention (71 % versus 39 %,
p = 0.001). We observed no significant difference in the
use of IABP between both groups (p = 0.969). Within the
group of survivors, 39 (78 %) patients had a CPC 1 and
11 (22 %) had a CPC 2 at 180 days post-CA. None of
the survivors had a CPC 3 or CPC 4. Twelve patients
died within 48 hours, with a mean age of 67 years ± 11,
of whom four (33 %) were women. The mean SctO2 of
these patients was 65 % ± 7. In Fig. 1 the course of the
hourly mean MAP, arterial oxygen partial pressure
(PaO2), arterial carbon dioxide partial pressure (PaCO2),
SvO2 and lactate during the first 48 hours is shown for
survivors and non-survivors.
The mean SctO2 of the first hour after admission at
the coronary care unit was 64 % ± 7 in survivors
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compared to 66 % ± 6 in non-survivors (p = 0.184). The
mean SctO2 over 48 hours was significantly higher in
the survivors (68 % ± 4) compared to non-survivors
(66 % ± 5; p = 0.035). The mean course of SctO2 in both
groups is given in Fig. 2. An initial decrease was ob-
served after initiation of TTM until hour 3 in survivors
(-5 % ± 6) and until hour 5 in non-survivors (-3 % ± 12;
p = 0.432) followed by a progressive increase in both
groups.
The first 48 hours of TTM at 33 °C after CA can be
divided in four different phases: the cooling phase,
followed by the hypothermia phase at 33 °C, the
rewarming phase and finally the normothermia phase.
The mean time to target temperature (cooling phase)
was 183 min ± 160 in both groups. The hypothermia
phase took 21 hours followed by a 12-hour rewarming
phase and a 12-hour normothermia phase. The results
of the mean SctO2 in each phase are listed in Table 2.
We observed a significant difference in the mean
SctO2 in the rewarming phase between survivors and
non-survivors (70 % ± 1 versus 68 % ± 1, p = 0.046).
No significant differences were observed in the other
phases.
If SctO2 values during the four different cooling
phases were compared between patients with and with-
out IABP, a difference was observed during the cooling
and hypothermia phase with higher SctO2 values in the
no-IABP group (p = 0.009 and p = 0.042). In the next
two phases, the rewarming (phase 3) and normothermia
phase (phase 4), no significant difference in SctO2 values
was observed between both groups (phase 3 - p = 0.722;
phase 4 - p = 0.827).
The area below a preset SctO2 threshold was calcu-
lated as well. Receiver operating curve (ROC) analysis
revealed the highest area under the curve (AUC) for a
SctO2 threshold of 55 % (AUC 0.58; specificity 52 % and
sensitivity 62 %).
If data were fitted in an optimal mixed model, a
significant difference was observed between survivors
and non-survivors concerning the course of SctO2
after adjustment for age and gender (p < 0.001) (Fig. 3).
Between female survivors and non-survivors we ob-
served a significant difference already from the start
of TTM at 33 °C with a logarithmic course of SctO2
in the survivors group versus a linear one in the non-
survivor group. Male survivors and non-survivors had
initially similar SctO2 values but during induction of
hypothermia, SctO2 increased more rapidly in the
male survivors (logarithmic) compared to male non-
survivors (linear).
Discussion
In this study, SctO2 was prospectively monitored in
OHCA patients with a presumed cardiac cause during
the initial 48 hours after admission to the CCU. This is
currently the largest post-resuscitation patient cohort
evaluated using SctO2 to prognosticate outcome. In all
patients TTM at 33 °C was applied for 24 hours,
followed by an active rewarming at 0.3 °C/hour. Within
this timeframe, we observed a significant different
course of SctO2 between survivors (CPC 1–2) and non-
survivors (CPC 5). In the rewarming phase, significant
higher SctO2 values were observed in patients with a
favorable neurological outcome. However, the clinical
Table 1 Patient demographics
All patients Survivors Non-survivors p value
Patients, n (%) 107 50 (47) 57 (53) /
Age, mean (± SD) 63 (13) 61 (13) 65 (13) 0.084
Gender, male/female, n (%) 75 (70)/32 (30) 40 (78)/11 (22) 35 (63)/21 (37) 0.072
Witnessed, n (%) 91 (85) 46 (92) 45 (79) 0.182
Bystander BLS, n (%) 59 (55) 28 (55) 31 (55) 0.962
Initial rhythm
VF, n (%) 66 (62) 42 (84) 24 (42) <0.001
PEA, n (%) 11 (10) 4 (8) 7 (12) 0.374
Asystole, n (%) 25 (23) 4 (8) 21 (37) <0.001
Time emergency call – ROSC (min) 30 ± 19 27 ± 17 34 ± 20 0.099
Cooling, endovascular/surface, n (%) 46 (43)/61(57) 26 (51)/25 (49) 20 (36)/36 (64) 0.111
Coronary angiography 87 (81) 46 (92) 41 (71) 0.008
PCI, n (%) 58 (54) 36 (72) 22 (39) 0.001
IABP, n (%) 25 (23) 12 (24) 13 (23) 0.969
BLS basic life support, VF ventricular fibrillation, PEA pulseless electrical activity, ROSC return of spontaneous circulation, PCI percutaneous coronary intervention,
IABP intra-aortic balloon pump
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significant difference we observed in SctO2 course is of
unlikely clinical meaning since this information is not
available at the bedside, and moreover it is so small that
at present clinicians will not be able to use any SctO2
cutoff value to predict outcome.
Experimental studies on CA and outcome revealed
that the severity of brain damage is mainly influenced by
the duration of the CA and by the mismatch in the
oxygen extraction rate (CEO2) to CBF during the post-
resuscitation period [13]. A better understanding of
cerebral hemodynamic disturbances may have an impact
on the post-CA management and may also allow a better
prognostication. Monitoring of SctO2 could provide a
non-invasive assessment of these cerebral hemodynamic
disturbances.
In recent years, several studies investigated whether
NIRS could be used during the post-CA stage to assist
with the neuroprognostication and as a therapeutic
target [6, 14, 15]. Overall, significant higher SctO2 were
observed at different time points in the post-CA phase
between patients with a favorable compared to unfavor-
able outcome. Nevertheless, the included patient popula-
tions were inhomogeneous (mix of OHCA and in-hospital
cardiac arrest (IHCA) patients), rather small in sample
size and mean SctO2 values over several hours were used.
In our patient cohort, we found the best AUC for a
threshold value of 55 %. However, this AUC had a very
low sensitivity and specificity. In contrast, Storm et al.
found the highest AUC for outcome prediction at a
SctO2 threshold of 50 % with a far higher sensitivity and
Fig. 1 Course of hemodynamic parameters, mean arterial pressure, arterial carbon dioxide pressure, arterial oxygen pressure, lactate and mixed
venous saturation. In this figure, the course for 48 hours of different hemodynamic parameters is shown as mean ± standard deviation. Overall
p values: MAP: p = 0.020; PaCO2: p = 0.842; PaO2: p = 0.370; lactate: p = 0.002; SvO2: p = 0.649. MAP mean arterial pressure, PaCO2 arterial carbon
dioxide tension, PaO2 arterial oxygen tension, SvO2 mixed venous saturation
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specificity (AUC 0.80; specificity 70 % and sensitivity
86 %) [14]. We should remark that they included 60
both IH- and OHCA patients of which 38 % had a good
neurological outcome compared to 47 % in our exclu-
sively OHCA patient population. In the setting of aortic
arch surgery, Fischer et al. showed that the time under
SctO2 thresholds of 55 %, 60 %, and 65 % was associated
with poor outcome [16]. In contrast to the perioperative
setting where treatment algorithms are proposed to treat
cerebral desaturations, no target SctO2 values are cur-
rently recommended in the post-CA phase.
In contrast to previous mentioned studies which
applied an hour-by-hour analysis, we performed a linear
mixed model analysis using continuous SctO2 data to in-
vestigate whether the SctO2 course over time was differ-
ent between survivors versus non-survivors [6, 14, 15]. If
all SctO2 values were fitted in a linear mixed model, a
significant time effect was observed during the SctO2
course. More specifically, survivors followed a logarith-
mic SctO2 course over time compared to a more linear
one for non-survivors. Based on these findings, it
seems possible that the balance between oxygen supply
and demand in survivors recovered more rapidly and
that non-survivors have longer-lasting disturbances in
cerebrovascular autoregulation. This implies that SctO2 in
non-survivors could be more dependent on hemodynamic
parameters such as MAP, CO, and PaCO2. Despite this
significant discordance in time course, which probably in-
dicates different underlying pathophysiologic mechanisms
between both patient groups, we should take into account
that this represents post hoc information, not available at
the bedside. The SctO2 course of both, male and female
patients with good favorable neurological outcome, follow
the same shape compared to the patients with unfavorable
outcome. However, the overall course of female survivors
is higher compared to the male survivors, which is more
or less also the case in the non-survivor group. Bickler et
al. observed no difference in gender using the FORE-
SIGHT technology to measure cerebral saturation in
healthy volunteers [17]. In this way a bias by the used
technology can be excluded. In healthy volunteers, re-
gional cerebral blood flow is higher in female volunteers
compared to male volunteers [18, 19]. In animal studies a
greater cerebral cortical blood flow and lower cerebral
oxygen extraction ratio was observed after severe cerebral
hemorrhage and ventricular fibrillation in females [20].
However, these studies were performed without the use of
TTM at 33 °C. All previous described findings might
explain the higher observed SctO2 in female patients if we
assume that TTM at 33 °C has a similar effect on both
sexes. Another explanation could be the number of in-
cluded female patients, which is only one third of the total
included population.
At the initiation of TTM at 33 °C, a decrease in mean
SctO2 was observed followed by a progressive increase in
mean SctO2 in both survivors and non-survivors. This de-
crease could be explained by the onset of different patho-
physiological mechanisms after CA. A period of delayed
cerebral hypoperfusion occurs which is associated with an
increase in cerebrovascular resistance, a drop in CBF, and
cerebral metabolic oxygen consumption [21, 22]. More-
over, it has been shown that blood viscosity is higher dur-
ing the initial hours after a CA [23–26]. As a significant
Fig. 2 Cerebral saturation course (mean ± standard deviation). 1 = time
to target temperature; 2 = therapeutic hypothermia; 3 = rewarming;
4 = normothermia. SctO2, cerebral tissue oxygen saturation
Table 2 Cerebral saturation values phase by phase
Survivors Non-survivors p value
Cerebral saturation (%)
Time to target temperature (0–3 h) 63 ± 2 64 ± 2 0.509
Therapeutic hypothermia (3–24 h) 65 ± 1 64 ± 1 0.076
Rewarming (24–36 h) 70 ± 1 68 ± 1 0.046
Normothermia (36–48 h) 72 ± 1 71 ± 1 0.217
Fig. 3 Fitted cerebral saturation by linear mixed models. SctO2, cerebral
tissue oxygen saturation
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negative correlation exists between blood viscosity and the
mean flow velocity of the middle cerebral artery, this
could explain the observed decrease in SctO2 [26]. Third,
hemodynamic parameters such as PaCO2, MAP, and CO
influence SctO2 [27]. Especially our observed decrease in
PaCO2 (50 mmHg until 40 mmHg) with its subsequent ef-
fects on cerebral vasculature and CBF could influence
SctO2 values [28]. Additionally, we observed a simultan-
eous decrease in MAP until 5–6 hours after the induction
of TTM at 33 °C together with a decrease in SctO2 sug-
gesting an impaired autoregulation. Cerebrovascular
autoregulation is known to be disturbed or right shifted
after a CA, which can influence SctO2 [21, 29]. Finally,
CO, in the initial phase after a CA, is relatively low due to
myocardial dysfunction [30]. We observed a decrease in
SvO2, and as SvO2 is highly correlated with CO, our ob-
served decrease in SctO2 can therefore be partially ex-
plained by a drop in CO [22, 30–32]. The hemodynamic
variability in the initial hours after CA as described above,
suggest the presence of a therapeutic window. Therefore,
hemodynamic parameters such as MAP and CO could be
optimized using an interventional protocol, which may
prevent the potential harming cerebral desaturation in the
early post-CA hours.
After the initial drop in mean SctO2, a progressive
increase in mean SctO2 was observed reaching stable
values around hour 12 and 22 in survivors and non-
survivors, respectively. This 10-hour delay in SctO2
recovery in non-survivors may implicate once more that
brain recovery from ischemia after CA is not similar in
survivors versus non-survivors. Since others described a
low CEO2 together with a gradual increase in mean flow
velocity until 48 hours after CA, our observed increase
in SctO2 6 hours after the start of TTM at 33 °C is
supported by these findings [13, 33]. In addition, TTM
at 33 °C induces a leftward shift of the oxygen dis-
sociation curve. This results in an enhanced affinity
of oxygen to hemoglobin, a phenomenon which may
explain the progressive increase in SctO2 as well.
During the rewarming phase, using a rewarming rate of
0.3 °C/hour, we observed significant higher SctO2 values
in survivors compared to non-survivors (p = 0.046). This
finding has probably an influence on the statistical
difference we observed in the overall course of SctO2. The
optimal rewarming rate in post-CA patients (after TTM at
33 °C) is not known thus far. But both animal and human
studies performed during cardiac surgery suggest a detri-
mental effect of rapid rewarming at the expense of poten-
tial neuroprotective effects of therapeutic hypothermia
(TH) [34–37]. Therefore, our results can only indicate
that rewarming has a different influence on cerebral
hemodynamics in survivors versus non-survivors.
If a sub-analysis is performed comparing patients with
and without an IABP, significant higher SctO2 values are
observed during cooling and hypothermia in the no-IABP
group. This represents probably the higher hemodynamic
instability of patients receiving an IABP.
Our study has several limitations. First, we did not
assess cerebral hemodynamic parameters by transcranial
Doppler. The continuous measurement of both SctO2
and cerebral hemodynamic parameters could have
allowed a better understanding of cerebral hemodynamic
changes in post-CA patients. Second, SctO2 was mea-
sured using NIRS technology on the forehead. This is a
regional measurement with the disadvantage that we do
not have any information other than the frontal region.
The number of patients included was rather limited but
as far as we know, this study is currently the largest in
which SctO2 is prospectively measured in post-CA
patients. Nevertheless, we suppose that extending the
number of patients will be of no added value for a
better understanding of the underlying pathophysiologic
mechanism responsible for the observed SctO2 course.
For this purpose, an experimental setting using non-
invasive as well as invasive cerebral hemodynamic
measurements could provide more valuable information.
At last, in this study SctO2 was measured during TTM at
33 °C. Consequently, these findings might not be
applicable to patients treated with TTM at 36 °C. More
importantly, significant higher SctO2 values were mea-
sured in the favorable neurological outcome group during
the rewarming phase, which is absent in post-CA patients
treated with TTM at 36 °C.
Conclusion
This study represents the largest post-resuscitation
cohort evaluated using NIRS technology, including a
sizeable cohort of balloon-assisted patients. Although
a significant difference was observed in the overall
course of SctO2 between OHCA patients with a fa-
vorable and unfavorable outcome, the margin was too
small to likely represent functional outcome differen-
tiation based on SctO2 alone. As such, these results
given such methodology as performed in this study
suggest that NIRS is insufficient by itself to serve in
outcome prognostication, but there may remain bene-
fit when incorporated into a multi-neuromonitoring
bedside assessment algorithm.
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